'2+1' Tricarbonyltechnetium(I) and -rhenium(I) mixed-ligand complexes with N-methylpyridine-2-carboxyamide and isocyanide or imidazole ligands-potential precursors of radiopharmaceuticals

Applied Radiation and Isotopes

Volumn 68, Issue 1, 2010, Pages 90-95

  Fuks, L ^a   Gniazdowska, E ^a   Kozminski, P ^a   Lyczko, M ^a   Mieczkowski, J ^b   Narbutt, J ^a  

^a INSTITUTE OF NUCLEAR CHEMISTRY AND TECHNOLOGY   (Poland)

^b UNIVERSITY OF WARSAW   (Poland)

Author keywords

Imidazole; Isocyanide; Lipophilicity; N methylpyridine 2 carboxyamide; Stability; Tricarbonylrhenium(I); Tricarbonyltechnetium(I)

Indexed keywords

IMIDAZOLE; ISOCYANIDE; LIPOPHILICITY; N-METHYLPYRIDINE-2-CARBOXYAMIDE; TRICARBONYLRHENIUM(I); TRICARBONYLTECHNETIUM(I);

BIOCHEMISTRY; COMPLEXATION; CYANIDES; LIGANDS; RHENIUM; TECHNETIUM;

RHENIUM COMPOUNDS;

CYSTEINE; HISTIDINE; IMIDAZOLE; LIGAND; N METHYLPYRIDINE 2 CARBOXYAMIDE; RHENIUM 188; TECHNETIUM 99M; TERT BUTYL 3 ISOCYANOPROPIONATE; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPOPHILICITY; NONHUMAN; OXIDATION; PARTITION COEFFICIENT; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; RAT;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTEINE; DRUG STABILITY; HISTIDINE; IMIDAZOLES; ISOCYANATES; LIGANDS; NICOTINIC ACIDS; ORGANOMETALLIC COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PROPIONATES; RADIOISOTOPES; RADIOPHARMACEUTICALS; RATS; RHENIUM; TECHNETIUM;

EID: 70449535556     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2009.07.016     Document Type: Article

References (9)

1. 3] and its substitution behaviour in water and organic solvents. J. Organomet. Chem. 493 1-2 (1995) 119-127
2. Alberto R. New organometallic technetium complexes for radiopharmaceutical imaging. Top. Curr. Chem. 252 (2005) 1-44
3. Fuks L., Gniazdowska E., Mieczkowski J., and Sadlej-Sosnowska N. Structural features of tricarbonyl(N-methyl-2-pyridinecarboxyamide)chloro-rhenium(I)-potential precursor of radiopharmaceuticals. Polyhedron 27 5 (2008) 1353-1360
4. 99mTc, Re) fragment to biomolecules. J. Organomet. Chem. 689 (2004) 4757-4763
5. +: a basic study. J. Chem. Soc., Dalton Trans. 9 (2004) 1320-1328
6. Narbutt, J., Czerwinski, M., Zasepa, M., 2005. Tricarbonyltechnetium(I) complexes with N,O- and N,S-donating ligands-theoretical and radiochemical studies. In: Chander, K., Acharya, R., Tomar, B.S., Venugopal, V. (Eds.), NUCAR 2005, Proceedings of the DAE-BRNS Symposium on Nuclear and Radiochemistry, Amritsar, India, BARC, Trombay, Mumbai, pp. 64-67.
7. Narbutt, J., Zasepa-Lyczko, M., Czerwinski, M., Schibli, R., 2007. Tricarbonyltechnetium(I) complexes with neutral bidentate ligands-N-methyl-2-pyridinecarboamide and N-methyl-2-pyridinecarbothioamide: experimental and theoretical studies. In: Pillai, M.R.A., Solanki, K.K. (Eds.), Trends in Radiopharmaceuticals (ISTR-2005), Proceedings Series, IAEA, Vienna, pp. 61-62.
8. Product Properties Test Guidelines OPPTS 830.7550, 1996. Partition coefficient (n-octanol/water), shake flask method. EPA 712-C-96-038, US Environmental Protection Agency.
9. 3-DEDT complex as a potential new radiopharmaceutical for brain imaging. J. Radioanal. Nucl. Chem. 272 1 (2007) 91-94